Efficacy of antiepileptic drugs in the adjunctive treatment of refractory partial-onset seizures: Meta-analysis of pivotal trials
Author:
Publisher
Elsevier BV
Subject
Neurology (clinical),Neurology
Reference75 articles.
1. Gabapentin (neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study;Anhut;Epilepsia,1994
2. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures;Arroyo;Epilepsia,2004
3. Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: a post-hoc study;Asadi-Pooya;Epilepsy Res.,2017
4. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy;Barcs;Epilepsia,2000
5. Efficacy and tolerability of levetiracetam 3000mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European levetiracetam study group;Ben-Menachem;Epilepsia,2000
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and safety of add‐on antiseizure medications for focal epilepsy: A network meta‐analysis;Epilepsia Open;2024-06-18
2. Antiseizure medication and SUDEP – a need for unifying methodology in research;Frontiers in Neurology;2024-04-17
3. Overnight switch from carbamazepine to eslicarbazepine in a real-life clinical scenario: a retrospective study;Neurological Sciences;2024-02-05
4. Vigabatrin (Sabril) for the Treatment of Refractory Complex Focal Seizures in Adults: Pharmacologic and Clinical Considerations;Cureus;2023-10-03
5. Pyridoxine for treatment of levetiracetam-induced behavioral adverse events: A randomized double-blind placebo-controlled trial;Epilepsy & Behavior;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3